Health Care & Life Sciences » Biotechnology | Abcam PLC

Abcam PLC

Abcam PLC
Stock Exchange Other OTC
EPS
 $0.37
Market Cap
 $3.76 B
Shares Outstanding
 205.1 M
Public Float
 -
Abcam PLC ADR
Stock Exchange Other OTC
EPS
 $0.37
Market Cap
 $3.89 B
Shares Outstanding
 205.63 M
Public Float
 -
Abcam PLC
Stock Exchange London Stock Exchange
EPS
 GBP27.92
Market Cap
 GBP3.02 B
Shares Outstanding
 205.08 M
Public Float
 175.84 M

Profile

Address
330 Cambridge Science Park
Cambridge East Anglia CB4 0FL
United Kingdom
Employees -
Website http://abcam.com
Updated 07/08/2019
Abcam Plc distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. The company was founded by Adam Robert David Cleevely, Anthony Kouzarides and Jonathan Milner on February 12, 1998 and is headquartered in Cambridge, the United Kingdom.

Financials

View All

Alan Thomas Hirzel
Chief Executive Officer & Executive Director
Gavin Wood
Chief Financial Officer & Executive Director
View All

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.